163 related articles for article (PubMed ID: 6176107)
21. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
Atlas SA; Niarchos AP; Case DB
Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
[No Abstract] [Full Text] [Related]
23. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
24. Influence of the renin-angiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs.
Persson P; Ehmke H; Kirchheim H
Acta Physiol Scand; 1988 Sep; 134(1):1-7. PubMed ID: 3239413
[TBL] [Abstract][Full Text] [Related]
25. The kidney and strategies for the treatment of hypertension.
Hollenberg NK
Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
[TBL] [Abstract][Full Text] [Related]
26. The renal response to converting enzyme inhibition and the treatment of sodium-sensitive hypertension.
Hollenberg NK; Williams GH
Clin Exp Hypertens A; 1987; 9(2-3):531-41. PubMed ID: 3038417
[TBL] [Abstract][Full Text] [Related]
27. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
Packer M; Lee WH; Kessler PD
Circulation; 1986 Oct; 74(4):766-74. PubMed ID: 3019586
[TBL] [Abstract][Full Text] [Related]
28. Intrarenal and systemic actions of the renin-angiotensin system. Implications for renal excretory function and sodium homeostasis.
Hollenberg NK
Contrib Nephrol; 1984; 43():102-13. PubMed ID: 6207980
[No Abstract] [Full Text] [Related]
29. Effect of the angiotensin converting enzyme inhibitor, captopril (SQ14,225), on orthostatic sodium and water retention in patients with idiopathic edema.
Suzuki H; Fujimaki M; Nakane H; Saito I; Takeshita E; Saruta T
Nephron; 1985; 39(3):244-9. PubMed ID: 2983253
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin and the renal circulation in hypertension.
Hollenberg NK; Williams GH
Circulation; 1988 Jun; 77(6 Pt 2):I59-63. PubMed ID: 3286047
[TBL] [Abstract][Full Text] [Related]
31. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
Chiba S; Quilley CP; McGiff JC
Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
[TBL] [Abstract][Full Text] [Related]
32. Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure.
Suki WN
Arch Intern Med; 1989 Mar; 149(3):669-73. PubMed ID: 2537612
[TBL] [Abstract][Full Text] [Related]
33. Development and pharmacology of angiotensin converting enzyme inhibitors.
Antonaccio MJ
J Pharmacol; 1983; 14 Suppl 3():29-45. PubMed ID: 6323887
[TBL] [Abstract][Full Text] [Related]
34. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
Hollenberg NK; Swartz SL; Passan DR; Williams GH
N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
[TBL] [Abstract][Full Text] [Related]
35. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
36. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
Zimmerman BG; Goering JL; Raich PC
Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
[TBL] [Abstract][Full Text] [Related]
37. Development and design of specific inhibitors of angiotensin-converting enzyme.
Cushman DW; Cheung HS; Sabo EF; Ondetti MA
Am J Cardiol; 1982 Apr; 49(6):1390-4. PubMed ID: 6176105
[TBL] [Abstract][Full Text] [Related]
38. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
39. Converting enzyme activity in regulation of blood pressure and kidney function. A review.
Piryova B; Girchev R
Cor Vasa; 1984; 26(6):401-7. PubMed ID: 6098419
[No Abstract] [Full Text] [Related]
40. Angiotensin-converting enzyme inhibitors.
Dipalma JR
Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
